Neurodevelopmental Dimensional Assessment and Genomic Risk of Neuropsychiatric Conditions

Duration: 20 mins Publication Date: 12 Dec 2023 Next Review Date: 12 Dec 2026 DOI: 10.13056/acamh.25584

Description

In this Papers Podcast, Dr. Sam Chawner discusses his JCPP Advances paper ‘Neurodevelopmental dimensional assessment of young children at high genomic risk of neuropsychiatric conditions’. Sam is the first author of the paper.

Learning Objectives

1. What are copy-number variants (CNVs) and how they impact child development.
2. Insight into what 22q11.2 deletion syndrome is, how it is typically diagnosed, and how it is associated with psychiatric risk.
3. Implications for clinicians and CAMH professionals.
4. Whether there are adequate interventions targeted at early age groups.
5. Recommendations for prevention, detection, and the targeting of interventions.

Related Content Links

JCPP Advances

Paper Link

https://doi.org/10.1002/jcv2.12162

About this Lesson

Symptoms:

none
The Association for Child and Adolescent Mental Health
We're a Living Wage Employer
© 2025 ACAMH
St Saviour’s House, 39-41 Union Street, London SE1 1SD
+44 (0)20 7403 7458
DISCLAIMER: While all transcripts were created by professional transcribers (unless otherwise stated), some may contain mistranslations resulting in inaccurate or nonsensical word combinations, or unintentional language. ACAMH is not responsible and will not be held liable for damages, financial or otherwise, that occur as a result of transcript inaccuracies.
}